Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2006-11-21
2006-11-21
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C424S434000, C424S489000, C514S909000, C514S866000
Reexamination Certificate
active
07138107
ABSTRACT:
The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.
REFERENCES:
patent: 4605552 (1986-08-01), Fritschi
patent: 5858967 (1999-01-01), Weigle et al.
patent: 6100047 (2000-08-01), Wilkison et al.
patent: 2003/0032595 (2003-02-01), Desir et al.
patent: 0967214 (1999-06-01), None
patent: WO 9002737 (1990-03-01), None
patent: WO 02/100248 (2002-12-01), None
Watt, W.C. and Storms, D.R., J. Biol. Chem., 2001; 276(1):2047-2052.
Wong et al., Neuron, 2000; 27:487-97.
Amer et al., “Intranasal administration of the calcium channel blocker diltiazem decreases food intake in hyperphagic rats,” Appetite 2003;40:315 (Jul. 15-19, 2003).
Amer et al., “Nasal administration of the calcium channel blocker diltiazem decreases food intake in hyperphagic rats,” Society for Study of Ingestive Behaviors (Jul. 20, 2003).
Arner,Int. J. Obes., 1993; 17(1):S57-S59.
Astrup et al.,Int. J. Obes., 1992; 16:269-277.
Astrup et al.,Am. J. Clin. Nutr., 1990; 51:759-767.
Rippe, (ed)., In: The obesity epidemic: Challenges and opportunities,J. Am. Dietetic Assoc., 1998; 98(2):S5.
Rissanen et al.,British Medical Journal, 1990; 301:835-837.
Scott,J. Neurosci., 2000; 15:4721-31.
Adams Christopher P.
Flynn James
Compellis Pharmaceuticals
Darby & Darby
Haghighatian Mina
Richter Johann
LandOfFree
Inhibition of olfactory neurosensory function to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of olfactory neurosensory function to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of olfactory neurosensory function to treat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3690119